{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T09:04:42Z","timestamp":1782983082588,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012468","name":"Distinguished Young Scientific Research Talents Plan in Universities of Fujian Province","doi-asserted-by":"publisher","award":["XMMC-FCTM201904"],"award-info":[{"award-number":["XMMC-FCTM201904"]}],"id":[{"id":"10.13039\/501100012468","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602974"],"award-info":[{"award-number":["81602974"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB20000000"],"award-info":[{"award-number":["XDB20000000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2018J05145"],"award-info":[{"award-number":["2018J05145"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejphar.2021.174561","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T20:35:49Z","timestamp":1634157349000},"page":"174561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["NAAA inhibitor F96 attenuates BBB disruption and secondary injury after traumatic brain injury (TBI)"],"prefix":"10.1016","volume":"912","author":[{"given":"Yitian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canzhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8257-2253","authenticated-orcid":false,"given":"Yuhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejphar.2021.174561_bib1","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.bbi.2012.07.021","article-title":"Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice","volume":"26","author":"Ahmad","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2021.174561_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2012.08.006","article-title":"Reduction of ischemic brain injury by administration of palmitoylethanolamide after transient middle cerebral artery occlusion in rats","volume":"1477","author":"Ahmad","year":"2012","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.ejphar.2021.174561_bib3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.bbalip.2017.01.001","article-title":"N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation","volume":"1862","author":"Alhouayek","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"5","key":"10.1016\/j.ejphar.2021.174561_bib4","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1046\/j.1471-4159.2003.02244.x","article-title":"Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia?","volume":"88","author":"Berger","year":"2004","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174561_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2005.06.019","article-title":"Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury","volume":"388","author":"Besson","year":"2005","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.ejphar.2021.174561_bib6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1124\/jpet.115.230516","article-title":"An important role for N-acylethanolamine acid amidase in the complete freund's adjuvant rat model of arthritis","volume":"356","author":"Bonezzi","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2021.174561_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2018.03.007","article-title":"N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities","author":"Bottemanne","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2021.174561_bib8","doi-asserted-by":"crossref","DOI":"10.1007\/s12975-018-0683-2","article-title":"Hypoxia-induced MicroRNA-212\/132 alter blood-brain barrier integrity through inhibition of tight junction-associated proteins in human and mouse brain microvascular endothelial cells","author":"Burek","year":"2019","journal-title":"Transl Stroke Res"},{"issue":"11","key":"10.1016\/j.ejphar.2021.174561_bib9","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1161\/hs1101.098367","article-title":"Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats","volume":"32","author":"Chen","year":"2001","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.ejphar.2021.174561_bib10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/SHK.0b013e318267bbb9","article-title":"Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice","volume":"38","author":"Di Paola","year":"2012","journal-title":"Shock"},{"issue":"9475","key":"10.1016\/j.ejphar.2021.174561_bib11","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(05)66552-X","article-title":"Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months","volume":"365","author":"Edwards","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2021.174561_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.phrs.2014.05.009","article-title":"Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury","volume":"86","author":"Esposito","year":"2014","journal-title":"Pharmacol. Res. : the official journal of the Italian Pharmacological Society"},{"issue":"1","key":"10.1016\/j.ejphar.2021.174561_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.nbd.2008.09.015","article-title":"The endocannabinoid system is modulated in response to spinal cord injury in rats","volume":"33","author":"Garcia-Ovejero","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2021.174561_bib14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12974-018-1303-5","article-title":"Effect of PEA-OXA on neuropathic pain and functional recovery after sciatic nerve crush","volume":"15","author":"Gugliandolo","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"12","key":"10.1016\/j.ejphar.2021.174561_bib15","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1111\/bph.13106","article-title":"Endocannabinoids modulate human blood-brain barrier permeability in vitro","volume":"172","author":"Hind","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.ejphar.2021.174561_bib16","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1089\/neu.2016.4808","article-title":"N-Palmitoylethanolamine-Oxazoline as a new therapeutic strategy to control neuroinflammation: neuroprotective effects in experimental models of spinal cord and brain injury","volume":"34","author":"Impellizzeri","year":"2017","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ejphar.2021.174561_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neuropharm.2018.08.004","article-title":"Pathophysiology and treatment of cerebral edema in traumatic brain injury","volume":"145","author":"Jha","year":"2019","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.ejphar.2021.174561_bib18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1474-4422(18)30469-1","article-title":"Traumatic brain injury in China","volume":"18","author":"Jiang","year":"2019","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.ejphar.2021.174561_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033537","article-title":"Site-specific and time-dependent activation of the endocannabinoid system after transection of long-range projections","volume":"7","author":"Kallendrusch","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174561_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.phrs.2018.03.011","article-title":"Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215","volume":"132","author":"Li","year":"2018","journal-title":"Pharmacol. Res. : the official journal of the Italian Pharmacological Society"},{"issue":"1","key":"10.1016\/j.ejphar.2021.174561_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174561_bib22","doi-asserted-by":"crossref","DOI":"10.1089\/neu.2018.6063","article-title":"Role of CB2 receptor in the recovery of mice after traumatic brain injury","author":"Magid","year":"2019","journal-title":"J. Neurotrauma"},{"issue":"37","key":"10.1016\/j.ejphar.2021.174561_bib23","doi-asserted-by":"crossref","first-page":"11193","DOI":"10.1002\/anie.201603746","article-title":"Second-generation non-covalent NAAA inhibitors are protective in a model of multiple sclerosis","volume":"55","author":"Migliore","year":"2016","journal-title":"Angew. Chem."},{"key":"10.1016\/j.ejphar.2021.174561_bib24","doi-asserted-by":"crossref","first-page":"105064","DOI":"10.1016\/j.phrs.2020.105064","article-title":"N-Acylethanolamine Acid Amidase contributes to disease progression in a mouse model of multiple sclerosis","volume":"160","author":"Pontis","year":"2020","journal-title":"Pharmacol. Res. : the official journal of the Italian Pharmacological Society"},{"key":"10.1016\/j.ejphar.2021.174561_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbi.2018.03.033","article-title":"Cellular players that shape evolving pathology and neurodegeneration following traumatic brain injury","volume":"71","author":"Puntambekar","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"37","key":"10.1016\/j.ejphar.2021.174561_bib26","doi-asserted-by":"crossref","first-page":"22699","DOI":"10.1039\/C7RA02237A","article-title":"Design and synthesis of uracil urea derivatives as potent and selective fatty acid amide hydrolase inhibitors","volume":"7","author":"Qiu","year":"2017","journal-title":"RSC Adv."},{"issue":"21","key":"10.1016\/j.ejphar.2021.174561_bib27","doi-asserted-by":"crossref","first-page":"12455","DOI":"10.1039\/C6RA28734D","article-title":"Design, synthesis, and biological evaluation of oxazolidone derivatives as highly potent N-acylethanolamine acid amidase (NAAA) inhibitors","volume":"7","author":"Ren","year":"2017","journal-title":"RSC Adv."},{"issue":"8","key":"10.1016\/j.ejphar.2021.174561_bib28","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1021\/acschembio.5b00114","article-title":"A potent systemically active N-acylethanolamine acid amidase inhibitor that suppresses inflammation and human macrophage activation","volume":"10","author":"Ribeiro","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejphar.2021.174561_bib29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fncel.2015.00323","article-title":"Stretch and\/or oxygen glucose deprivation (OGD) in an in vitro traumatic brain injury (TBI) model induces calcium alteration and inflammatory cascade","volume":"9","author":"Salvador","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174561_bib30","doi-asserted-by":"crossref","first-page":"10523","DOI":"10.1038\/ncomms10523","article-title":"Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury","volume":"7","author":"Shi","year":"2016","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.ejphar.2021.174561_bib31","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMra1208708","article-title":"Traumatic intracranial hypertension","volume":"370","author":"Stocchetti","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ejphar.2021.174561_bib32","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/cbdv.200790159","article-title":"The N-acylethanolamine-hydrolyzing acid amidase (NAAA)","volume":"4","author":"Tsuboi","year":"2007","journal-title":"Chem. Biodivers."},{"issue":"5","key":"10.1016\/j.ejphar.2021.174561_bib33","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbalip.2007.03.005","article-title":"Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies","volume":"1771","author":"Tsuboi","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"26","key":"10.1016\/j.ejphar.2021.174561_bib34","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa1404304","article-title":"Very early administration of progesterone for acute traumatic brain injury","volume":"371","author":"Wright","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.174561_bib35","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3389\/fphar.2019.00818","article-title":"A new use for an old drug: carmofur attenuates lipopolysaccharide (LPS)-Induced acute lung injury via inhibition of FAAH and NAAA activities","volume":"10","author":"Wu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174561_bib36","series-title":"Tissue Plasminogen Activator Promotes White Matter Integrity and Functional Recovery in a Murine Model of Traumatic Brain Injury","author":"Xia","year":"2018"},{"issue":"4","key":"10.1016\/j.ejphar.2021.174561_bib37","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1089\/neu.2016.4491","article-title":"Glibenclamide attenuates blood-brain barrier disruption in adult mice after traumatic brain injury","volume":"34","author":"Xu","year":"2017","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ejphar.2021.174561_bib38","doi-asserted-by":"crossref","first-page":"13565","DOI":"10.1038\/srep13565","article-title":"Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-alpha","volume":"5","author":"Yang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174561_bib39","article-title":"Inhibition of transient receptor potential vanilloid 1 attenuates blood-brain barrier disruption after traumatic brain injury in mice","author":"Yang","year":"2018","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ejphar.2021.174561_bib40","doi-asserted-by":"crossref","first-page":"104264","DOI":"10.1016\/j.phrs.2019.104264","article-title":"N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis","volume":"145","author":"Zhou","year":"2019","journal-title":"Pharmacol. Res. : the official journal of the Italian Pharmacological Society"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921007172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921007172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:15:22Z","timestamp":1762143322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921007172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":40,"alternative-id":["S0014299921007172"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174561","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NAAA inhibitor F96 attenuates BBB disruption and secondary injury after traumatic brain injury (TBI)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174561","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174561"}}